Optimi Health Corp. (NASDAQ:OPTH) Short Interest Update

Optimi Health Corp. (NASDAQ:OPTH) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 20,776 shares, a decline of 71.2% from the July 15th total of 72,205 shares. Based on an average trading volume of 34,203 shares, the days-to-cover ratio is presently 0.6 days. Currently, 0.4% of the shares of the stock are sold short.

Optimi Health Stock Down 0.8%

Shares of OPTH stock traded down $0.04 during mid-day trading on Friday, hitting $4.79. 23,229 shares of the company’s stock were exchanged, compared to its average volume of 27,536. Optimi Health has a fifty-two week low of $4.00 and a fifty-two week high of $6.40. The company has a 50-day simple moving average of $4.69. The company has a current ratio of 0.06, a quick ratio of 0.03 and a debt-to-equity ratio of 0.04. The stock has a market capitalization of $27.45 million and a PE ratio of -13.31.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Weiss Ratings started coverage on Optimi Health in a research report on Thursday, May 21st. They set a “sell (d-)” rating for the company. Wall Street Zen raised shares of Optimi Health to a “hold” rating in a research note on Saturday, July 25th. Finally, Zacks Research upgraded shares of Optimi Health to a “hold” rating in a report on Thursday, May 28th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.

Optimi Health Company Profile

Optimi Health Corp. is a commercial-stage pharmaceutical company focused on manufacturing and distributing GMP-grade psychedelic drug products for mental health therapies. Optimi Health Corp. is based in VANCOUVER, BC.